Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.

The Journal of rheumatology·2026
Same author

Telehealth Treatments of Common Psychological Disorders: An Overview and Meta-analysis.

Journal of occupational rehabilitation·2026
Same author

The Multidisciplinary Support To Access living donor Kidney Transplant (MuST AKT) intervention: A Pilot Randomized Controlled Trial.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Sex and gender reporting in RCTs of internet and mobile-based interventions for depression and anxiety in chronic conditions: A secondary analysis of a systematic review.

PLOS mental health·2026
Same author

Does the format of the adult ADHD self-report scale influence screen-positive rates? A randomized controlled trial in primary care.

Frontiers in psychiatry·2026
Same author

Risk of new diagnoses and exacerbations of chronic conditions after SARS-CoV-2 infection: a systematic review update.

Epidemiologic reviews·2025
Same journal

Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update).

Evidence report/technology assessment·2018
Same journal

Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.

Evidence report/technology assessment·2018
Same journal

Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Evidence report/technology assessment·2018
Same journal

The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain.

Evidence report/technology assessment·2018
Same journal

Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.

Evidence report/technology assessment·2018
Same journal

Health Information Exchange.

Evidence report/technology assessment·2018
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Exercise-induced bronchoconstriction and asthma.

Donna M Dryden, Carol H Spooner, Michael K Stickland

    Evidence Report/Technology Assessment
    |August 24, 2010
    PubMed
    Summary
    This summary is machine-generated.

    This study found no clear diagnostic replacement for the exercise challenge test (ECT) for exercise-induced bronchoconstriction (EIB). However, various bronchodilators and anti-inflammatories effectively attenuate EIB symptoms.

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
    09:58

    A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

    Published on: April 13, 2010

    Area of Science:

    • Pulmonary Medicine
    • Exercise Physiology
    • Diagnostic Accuracy

    Background:

    • Exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA) are common conditions affecting athletes and the general population.
    • Accurate diagnosis is crucial for effective management and treatment.

    Purpose of the Study:

    • To evaluate the diagnostic accuracy of alternative tests for EIB/EIA compared to a standardized exercise challenge test (ECT).
    • To assess the efficacy of pharmacological and non-pharmacological interventions in preventing EIB/EIA.
    • To investigate the development of tachyphylaxis with regular beta-agonist use in patients with EIA.

    Main Methods:

    • A systematic literature search was conducted across multiple databases for diagnostic and therapy studies.
    • Diagnostic test characteristics (sensitivity, specificity) were compared against the ECT.
    • Randomized controlled trials (RCTs) were analyzed for the efficacy of interventions using mean differences in FEV1 fall.

    Main Results:

    • No alternative diagnostic tests demonstrated sufficient accuracy to replace the ECT due to heterogeneity.
    • Leukotriene receptor antagonists (LTRA), mast cell stabilizers (MCS), ipratropium bromide, and interval warm-up routines significantly attenuated EIA.
    • Tachyphylaxis was observed with regular use of long-acting (LABA) and short-acting beta-agonists (SABA), although they still provided some protection.

    Conclusions:

    • The standardized exercise challenge test (ECT) remains the preferred diagnostic method for EIB/EIA.
    • Pre-exercise treatment with bronchodilators and anti-inflammatory agents is effective in attenuating EIA.
    • Clinicians should be aware of potential tachyphylaxis with chronic beta-agonist use.